Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ambre Lauret"'
Autor:
Marie Kostine, Christophe Richez, Thierry Schaeverbeke, Gael Mouterde, Marie-Elise Truchetet, Julien Henry, Rakiba Belkhir, Vincent Germain, Isabelle Bonnet, Chi Duc Nguyen, Thao Pham, Claire Brière, Léa Rouxel, Thierry Cardon, Fanny De La Fuente, Pierre Edouard Gavand, Céline Labadie, Ambre Lauret
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objective There is limited experience regarding the use of biological disease-modifying antirheumatic drug (bDMARD) and JAK inhibitor (JAKi) for the management of immune checkpoint inhibitors (ICI)-induced inflammatory arthritis. We aimed to assess t
Externí odkaz:
https://doaj.org/article/eed9e3a2d1ea4e8facaa4a0b25a6ee55
Autor:
Fanny De La Fuente, Rakiba Belkhir, Julien Henry, Chi Duc Nguyen, Thao Pham, Vincent Germain, Pierre Edouard Gavand, Céline Labadie, Claire Briere, Ambre Lauret, Thierry Cardon, Gael Mouterde, Isabelle Bonnet, Léa Rouxel, Marie-Elise Truchetet, Thierry Schaeverbeke, Christophe Richez, Marie Kostine
Publikováno v:
RMD open. 8(2)
ObjectiveThere is limited experience regarding the use of biological disease-modifying antirheumatic drug (bDMARD) and JAK inhibitor (JAKi) for the management of immune checkpoint inhibitors (ICI)-induced inflammatory arthritis. We aimed to assess th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d1b603ed0a321f47d920d6235d4b352
https://pubmed.ncbi.nlm.nih.gov/36270747
https://pubmed.ncbi.nlm.nih.gov/36270747
Autor:
Claire Goulvestre, O. Conort, Anna Molto, F. Chast, Christian Roux, Claire Le Jeunne, Vered Abitbol, Frédéric Batteux, Ambre Lauret, Stanislas Chaussade, Loriane Gutermann, Maxime Dougados, Jérôme Avouac, Yannick Allanore
Publikováno v:
Seminars in Arthritis and Rheumatism
Seminars in Arthritis and Rheumatism, WB Saunders, 2020, 50, pp.1449-1456. ⟨10.1016/j.semarthrit.2020.02.007⟩
Seminars in Arthritis and Rheumatism, 2020, 50, pp.1449-1456. ⟨10.1016/j.semarthrit.2020.02.007⟩
Seminars in Arthritis and Rheumatism, WB Saunders, 2020, 50, pp.1449-1456. ⟨10.1016/j.semarthrit.2020.02.007⟩
Seminars in Arthritis and Rheumatism, 2020, 50, pp.1449-1456. ⟨10.1016/j.semarthrit.2020.02.007⟩
International audience; Objective: To evaluatre the risk of immunogenicity in patients with chronic inflammatory diseases who experienced successive non-medical swiches to different biosimilars infliximab.Patients and methods: Observational study ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f60d9e0ab54e0562e3e76a461bfb7e3e
https://hal.archives-ouvertes.fr/hal-03493478
https://hal.archives-ouvertes.fr/hal-03493478
Autor:
Stanislas Chaussade, Claire Goulvestre, Jérôme Avouac, Anna Molto, Ambre Lauret, Yannick Allanore, Vered Abitbol, Maxime Dougados, Christian Roux, O. Conort, Loriane Gutermann, F. Chast, Claire Le Jeunne, Frédéric Batteux
Publikováno v:
Oral Presentations.
Background Objectives To determine whether the successive switches from innovator infliximab to a first then a second biosimilar infliximab increase the risk of immunogenicity during a 3-year observation period. Methods This is a usual care study per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5a9a9fc96558e116cb9765a478e5041
https://doi.org/10.1136/annrheumdis-2019-eular.3702
https://doi.org/10.1136/annrheumdis-2019-eular.3702